Skip to main content
OpenTrials

Clinical trial condition

Erythropoietic Protoporphyria

Explore clinical trials studying Erythropoietic Protoporphyria. Study availability and eligibility vary by location and protocol.

16 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Erythropoietic Protoporphyria trial results

Enrolling by Invitation

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

NCT05883748

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria, +10 more
Locations
  • University of Alabama Hospital Birmingham, Alabama, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Completed

Effect of Oral Cimetidine in the Protoporphyrias

NCT05020184

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria, +13 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Atrium Health Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States
  • University of Texas Medical Branch Galveston, Texas, United States
View Trial Details
Completed

Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP

NCT05308472

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria, +10 more
Locations
  • University of Alabama Hospital Birmingham, Alabama, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)

NCT00979745

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria, +10 more
Locations
  • HUS:n Iho-ja allergiasairaala (Skin and Allergy Hospital) Helsinki, Finland
  • Centre Français des Porphyries, Hôpital Louis Mourier Colombes, Cedex, France
  • Department of Dermatology , Heinrich-Heine-University Duesseldorf Düsseldorf, Germany
  • Beaumont Hospital, Department of Dermatology Dublin, Ireland
View Trial Details
Completed

Oral Iron for Erythropoietic Protoporphyrias

NCT02979249

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, EPP, +14 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • University of California San Francisco, California, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
View Trial Details
Completed

Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact

NCT01688895

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, EPP, +18 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • University of California, San Francisco San Francisco, California, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
View Trial Details
Completed

Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)

NCT01097044

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria, +10 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of California, San Francisco San Francisco, California, United States
  • Mt. Sinai New York, United States
  • Carolina's Medical Center Cannon Research Charlotte, North Carolina, United States
View Trial Details

Related conditions